| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003051A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock |
| 02/02/1995 | WO1995003039A1 N,n,n-trimethylsphingosine derivatives |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994026723A3 ras FARNESYL TRANSFERASE INHIBITORS |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167837A1 Vitamin d analogues |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167308A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | CA2165982A1 N,n,n-trimethylsphingosine derivatives |
| 02/01/1995 | EP0636372A1 Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636127A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 02/01/1995 | EP0636032A1 Method of intraoperatively detecting and locating tumoral tissues |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 02/01/1995 | CN1098105A Novel material, dolastachin C and application of same |
| 01/31/1995 | US5386016 Acylation of an aglcone in presence of a Lewis acid |
| 01/31/1995 | US5385944 Treating or preventing disorders of melatoninergic system |
| 01/31/1995 | US5385923 Treatment of degenerative diseases |
| 01/31/1995 | US5385917 Carboxylic acid derivatives |
| 01/31/1995 | US5385909 Heterocyclic esters of rapamycin |
| 01/31/1995 | US5385908 Immunosuppressants, antiinflammatory agents |
| 01/31/1995 | US5385904 Therapy for immunology diseases |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | CA1334200C Leukotriene antagonists |
| 01/31/1995 | CA1334170C Methods of treating tumors with compositions of catecholic butanes |
| 01/26/1995 | WO1995002751A1 Method for repairing a combustion chamber assembly |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002613A2 Heparin derivatives having antimetastatic activity |
| 01/26/1995 | WO1995002593A1 Piperazine derivatives and salts thereof |
| 01/26/1995 | WO1995002577A1 Novel vitamin d analogues |
| 01/26/1995 | WO1995002572A1 Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent |
| 01/26/1995 | WO1995002566A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses |
| 01/26/1995 | WO1995002420A2 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | WO1995002413A1 Suppression of inhibitors |
| 01/26/1995 | WO1995002400A1 Taxol derivatives |
| 01/26/1995 | WO1994028014A3 Peptide inhibitors of urokinase receptor activity |
| 01/26/1995 | WO1994026730A3 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
| 01/26/1995 | CA2167391A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses |
| 01/26/1995 | CA2167153A1 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | CA2167059A1 Heparin derivatives having antimetastatic activity |
| 01/26/1995 | CA2165079A1 Taxol derivatives |
| 01/26/1995 | CA2162040A1 Novel vitamin d analogues |
| 01/26/1995 | CA2144518A1 Process for preparing 5,8-dihydronaphtoquinone derivatives, novel 5,8-dihydronaphtoquinone derivatives and their use as anticancer agent |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | CA2143203A1 Piperazine derivatives and salts thereof |
| 01/25/1995 | EP0635507A1 Tricyclic derivatives and their use as anti-cancer agents |
| 01/25/1995 | EP0635498A1 Quinazoline derivatives and their use as anti-cancer agents |
| 01/25/1995 | EP0635479A1 Perylene quinones (UCN-1028 D) derivatives |
| 01/25/1995 | EP0635268A1 Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
| 01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
| 01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/25/1995 | EP0576619B1 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 01/25/1995 | EP0516849B1 Indole derivatives |
| 01/25/1995 | CN1097761A Polycyclic compounds and processes for the preparation thereof |
| 01/25/1995 | CN1097746A C10 taxane derivatives and pharmaceutical compositions containing them |
| 01/24/1995 | US5384399 Oxazinone compounds for the preparation of taxol |
| 01/24/1995 | US5384394 Polypeptides useful for treatment of leukemia or uterus tumors |
| 01/24/1995 | US5384310 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions |
| 01/24/1995 | CA2038409C Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 01/23/1995 | CA2128464A1 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparation |
| 01/20/1995 | CA2128046A1 Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
| 01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
| 01/19/1995 | WO1995002052A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/19/1995 | WO1995002051A2 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/19/1995 | WO1995001981A1 Novel substance dc114-a1 |
| 01/19/1995 | WO1995001980A1 Bicyclic tetrahydro pyrazolopyridines |
| 01/19/1995 | WO1995001960A1 Novel structural analogues of vitamin d |
| 01/19/1995 | WO1995001806A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/19/1995 | CA2166798A1 Pro-cytotoxic drug conjugates for anticancer therapy |
| 01/19/1995 | CA2166058A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2143437A1 Novel substance dc114-a1 |
| 01/19/1995 | CA2141417A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
| 01/18/1995 | EP0634414A1 Isolation and structure of spongistatins 5,7,8,and 9 and their use as antitumor agents |
| 01/18/1995 | EP0634401A1 MDR reversal agents |
| 01/18/1995 | EP0633937A1 Immunization by inoculatioon of dna transcription unit |
| 01/18/1995 | EP0633933A1 Leucine zippers |
| 01/18/1995 | EP0633930A1 In vitro generation of human dendritic cells and uses thereof |
| 01/18/1995 | EP0633893A1 17-substituted steroids useful in cancer treatment |
| 01/18/1995 | EP0633886A1 Pharmaceutically active bicyclic-heterocyclic amines |
| 01/18/1995 | EP0633785A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 01/18/1995 | EP0633774A1 Topical administration of toremifene and its metabolites |
| 01/18/1995 | EP0625045A4 Methods of treating inflammatory dermatoses. |
| 01/18/1995 | EP0621787A4 Skin therapeutic mixture containing cold-processed aloe vera extract, with yellow sap and aloin removed. |
| 01/18/1995 | EP0542891B1 Biologically active compounds from blue-green algae |
| 01/18/1995 | CN1097421A Adhesion receptor antagonists |